Healing America Through Innovation in Healthcare

Healthcare Innovation Journal

Subscribe to Healthcare Innovation Journal: eMailAlertsEmail Alerts newslettersWeekly Newsletters
Get Healthcare Innovation Journal: homepageHomepage mobileMobile rssRSS facebookFacebook twitterTwitter linkedinLinkedIn


Healthcare Innovation Authors: Yoel Knoll, Mark Hoover, LeanTaaS Blog, Ram Sonagara, Santosh Varughese

Related Topics: Health 2.0, Government News, Green Healthcare, Pharmaceutical News, Healthcare Innovation Journal, Government Innovation Journal

Opinion

Pharmaceutical Industry Set to Emerge as winners in the Healthcare Reform

Pharmaceutical Leaders are set to meet at the anticipated NGP US Summit Next week to discuss reform

Pharmaceutical News on Ulitzer

Once a powerful profit-machine, big pharma is stumbling, the threat of further government intervention, drying product pipelines, fierce competition from generic manufacturers, consumer concerns about safety, and false marketing claims is forcing leaders to revisit operations to secure top line Growth. So leaders such as Judith Marquis, Group VP Genzyme, Jeffrey Nye, Chief Medical Officer J&J Pharmaceuticals and James Kirwin VP Global Clinical Operation Wyeth Pharmaceuticals are uniting with over 50 other figureheads at the renowned NGP US Summit next week in Florida to discuss future technology investments to strengthen the industry and improve efficiency to "weather the Healthcare Reform".

Thomas Haverty - Global VP, Global Clinical Research, Schering-Plough is set to start proceedings and our sources tell us he will be talking about Responding to 21st Century Drug Development Challenge.

"While healthcare reform has dominated headlines, drug companies have come through the debate relatively untouched, but they need to invest wisely to strengthen under the inevitable changes," Drew Contessa NGP US Summit Director.

The good news for the pharmaceutical industry is that it may emerge as a winner in the healthcare reform battle as new customers enter the system and price protections remain in force.

IMS Health, the drug industry forecasting firm, reports that the global pharmaceutical industry will grow 4% to 6% in 2010, up to $825 billion.

It is not very often that the industries elite meet like this and it is clear that significant changes will be outlined as a result.

For more information www.ngpsummit.com.

More Stories By John Funnell

John Funnell has worked in online media for over ten years, after achieving his First Class BSC Hons Degree (BBC Sponsored), John won Bos 18-21 Princess Trust Entrepeneur of the year at 21, setting up Clean Living Records Ltd (including www.BeatReview.com) with great success having many acts that charted in Europe and Canada. After selling the business John looked for a new challenge and joined GDS International, having a successful career in sales and Delegate acquisition, he worked up to Event Director EMEA, forging contacts with some of the biggest technology names in the world, this lead to John having a lead role in the creation of MeettheBoss.com and MeettheBoss.tv – the worlds largest business IPTV channel. John then took over as Marketing and Communications Director and ran a multifaceted global Marketing team for GDS International in New York, Sydney, Kuala Lumper and the UK.. John joined Global in 2011 with the challenge of supporting its growth by developing a solid Marketing foundation through various Digital, PR and brand initiatives.